Streetbeat News

Products Services

DE

Mark Cuban criticized former President Donald Trump's approach to revitalizing U.S. manufacturing through tariffs, suggesting it is impractical and could harm companies like Deere & Company. Cuban argues that Trump's tariff strategy is akin to mandating all manufacturing in the U.S., which he believes is unrealistic.

Portfolio Pulse from Shivdeep Dhaliwal

October 16, 2024 | 1:41 am

CRLBF

GTBIF

JUSHF

TCNNF

VRNOF

Pennsylvania's GOP districts are increasingly supporting cannabis legalization due to economic distress, poverty, and the opioid crisis. This bipartisan support is seen as a potential solution for economic growth and harm reduction. The trend could serve as a model for other conservative states. Several cannabis companies, including Jushi Holdings, Cresco Labs, Green Thumb Industries, Verano Holdings, and Trulieve Cannabis, could benefit from potential legalization.

Portfolio Pulse from Nicolás Jose Rodriguez

October 16, 2024 | 1:33 am

MJNA

The U.S. Supreme Court is deliberating a case involving Douglas Horn, a truck driver fired after a failed drug test due to CBD use. Horn is suing under the RICO Act, claiming business injury. The case could impact the scope of RICO lawsuits.

Portfolio Pulse from Maureen Meehan

October 15, 2024 | 9:53 pm

FTNT

Fortinet, Inc. (NASDAQ:FTNT) has released a report warning of cyberthreats targeting the 2024 U.S. presidential election, including phishing scams, AI impersonations, and ransomware attacks. The report highlights increased cyber espionage activities from state-sponsored adversaries like China, Russia, and Iran. Fortinet emphasizes the importance of good cyber hygiene to protect against these threats.

Portfolio Pulse from Erica Kollmann

October 15, 2024 | 9:28 pm

BTCUSD

DOGEUSD

ETHUSD

Cryptocurrency markets are trading flat after a spike, with Bitcoin reaching $68K. Notable developments include Metaplanet's Bitcoin purchase and high Bitcoin spot ETF inflows. Analysts predict potential bullish momentum for Bitcoin.

Portfolio Pulse from Khyathi Dalal

October 15, 2024 | 8:53 pm

NVCR

Novocure announced that the FDA has approved its product, Optune Lua, for the treatment of metastatic non-small cell lung cancer. This approval could potentially enhance Novocure's market position and revenue prospects.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:44 pm

NVCR

NovoCure's shares rose following FDA approval of Optune Lua for treating metastatic non-small cell lung cancer.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:39 pm

URGN

UroGen Pharma's shares rose following the FDA's acceptance of its new drug application for UGN-102.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:35 pm

URGN

UroGen Pharma Ltd. announced that the FDA has accepted its New Drug Application for UGN-102, a potential treatment for low-grade intermediate-risk non-muscle invasive bladder cancer. The PDUFA goal date is set for June 13, 2025.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:32 pm

NISN

Nisun International projects continued momentum in its supply chain trading business through the second half of 2024 and into 2025. The company also anticipates a favorable environment for its SME financing and supply chain financing solutions.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 8:20 pm